Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

5.13USD
1 Aug 2013
Price Change (% chg)

$0.05 (+0.98%)
Prev Close
$5.08
Open
$5.07
Day's High
$5.14
Day's Low
$4.98
Volume
143,950
Avg. Vol
99,851
52-wk High
$6.84
52-wk Low
$2.30

SNSS.OQ

Chart for SNSS.OQ

About

Sunesis Pharmaceuticals, Inc. (Sunesis) is a biopharmaceutical company focused on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The Company is focuses primarily on the development of vosaroxin for the treatment of acute myeloid leukemia (AML). Vosaroxin is a... (more)

Overall

Beta: 2.14
Market Cap (Mil.): $262.17
Shares Outstanding (Mil.): 51.61
Dividend: --
Yield (%): --

Financials

  SNSS.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.83 -- --
ROI: -264.23 -2.58 18.76
ROE: -6,285.15 -2.66 19.59
Search Stocks

Competitors

  Price Change
Eisai Co., Ltd (4523.T) ¥4,295 +130.00
Pfizer Inc. (PFE.N) $29.11 -0.12
Johnson & Johnson (JNJ.N) $93.77 +0.27
Novartis AG (NOVN.VX) CHF66.60 +0.35
Merck & Co., Inc. (MRK.N) $48.58 +0.41
Celgene Corporation (CELG.OQ) $148.79 +1.93

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks